Comparable clinical course between coagulase-negative staphylococcal and Staphylococcus aureus endocarditis

Infection. 2022 Apr;50(2):483-490. doi: 10.1007/s15010-021-01738-y. Epub 2022 Jan 10.

Abstract

Purpose: Staphylococcus aureus (SA) is involved in almost one-third of endocarditis events (known as E-SA) and is frequently associated with unfavorable outcomes compared to infectious endocarditis (IE) caused by other pathogens including coagulase-negative staphylococci (CNS). The aim of this study was to compare the morbidity and mortality of patients with E-SA and endocarditis due to CNS (known as E-CNS).

Methods: A monocentric retrospective cohort analysis was conducted including all patients admitted with IE from January 2010 to December 2017. Lengths of stay, complications, in-hospital and 1-year mortality were described from medical records and compared between E-SA and E-CNS.

Results: Among the 428 patients included, 102 had staphylococcus (50 E-SA and 52 E-CNS). Half of the IE events due to staphylococcus occurred in the year following a cardiac procedure [p = 0.029]. A septic embolism occurred in 41% and 48% of patients with E-CNS and E-SA, respectively [p = 0.439]. Cardiac surgery was indicated in 50% of E-SA and 48% of E-CNS cases [p = 0.846]. The intra-hospital and 1-year mortality rates were 25% and 31% for E-CNS and 34% and 45% for E-SA [p = 0.699, p = 0.234].

Conclusion: Embolic complications, surgical management rate and mortality rates of E-SA and E-CNS were comparable, which may suggest a similar morbidity and mortality irrespective of the pathogen involved in IE.

Keywords: Antimicrobial therapy; Cardiac surgery; Coagulase-negative staphylococci; Endocarditis; Mortality; Staphylococcus aureus.

Publication types

  • Comparative Study

MeSH terms

  • Coagulase
  • Endocarditis* / surgery
  • Endocarditis, Bacterial*
  • Humans
  • Retrospective Studies
  • Staphylococcal Infections*
  • Staphylococcus
  • Staphylococcus aureus

Substances

  • Coagulase